Toshihiro Miyamoto - Publications

Affiliations: 
Kyushu University (Japan) 

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yoneshima Y, Kato K, Minami H, Ikeda M, Watanabe H, Yoshimoto G, Miyamoto T, Akashi K, Nakanishi Y, Okamoto I. HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors. Cancer Science. PMID 32557883 DOI: 10.1111/cas.14536  0.44
2020 Henzan H, Takase K, Kamimura T, Mori Y, Yoshimoto G, Iwasaki H, Nagafuji K, Ogawa R, Eto T, Uchida N, Fujisaki T, Kato K, Minami M, Kikushige Y, Akashi K, ... Miyamoto T, et al. Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. International Journal of Hematology. PMID 32524309 DOI: 10.1007/s12185-020-02911-z  0.44
2020 Yuda J, Odawara J, Minami M, Muta T, Kohno K, Tanimoto K, Eto T, Shima T, Kikushige Y, Kato K, Takenaka K, Iwasaki H, Minami Y, Ohkawa Y, Akashi K, ... Miyamoto T, et al. TKIs induce alternative spliced BCR-ABL variant via inhibition of RNA polymerase Ⅱ on genomic BCR-ABL. Cancer Science. PMID 32314454 DOI: 10.1111/cas.14424  0.44
2020 Yamasaki S, Yoshida S, Kato K, Choi I, Imamura Y, Kohno K, Henzan H, Tanimoto K, Ogawa R, Suehiro Y, Miyamoto T, Eto T, Ohshima K, Akashi K, Iwasaki H, et al. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma. International Journal of Hematology. PMID 32297159 DOI: 10.1007/s12185-020-02879-w  0.44
2020 Tochigi T, Miyamoto T, Hatakeyama K, Sakoda T, Ishihara D, Irifune H, Shima T, Kato K, Maeda T, Ito T, Handa H, Akashi K, Kikushige Y. Aromatase is a novel neo-substrate of cereblon responsible for immunomodulatory drugs-induced thrombocytopenia. Blood. PMID 32219443 DOI: 10.1182/blood.2019003749  0.44
2020 Jinnouchi F, Yamauchi T, Yurino A, Nunomura T, Nakano M, Iwamoto C, Obara T, Miyawaki K, Kikushige Y, Kato K, Maeda T, Miyamoto T, Baba E, Akashi K, Takenaka K. Establishment of a human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells. Blood. PMID 32206775 DOI: 10.1182/blood.2019002194  0.44
2020 Harada T, Kuriyama T, Nishida R, Yoshimoto G, Mori Y, Imanaga H, Ueno T, Odawara J, Hayashi M, Kato K, Takenaka K, Akashi K, Miyamoto T. Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 32146107 DOI: 10.1016/j.jiac.2019.12.013  0.44
2020 Ishida S, Morikawa H, Watanabe H, Tsuji T, Sugio T, Mori Y, Miyamoto T, Masuda S, Akashi K, Egashira N. Increasing Diluent Volume Decreases Bendamustine-Induced Venous Irritation without Reducing the Therapeutic Efficacy. Biological & Pharmaceutical Bulletin. 43: 488-492. PMID 32115507 DOI: 10.1248/bpb.b19-00826  0.44
2020 Mori Y, Choi I, Yoshimoto G, Muta T, Yamasaki S, Tanimoto K, Kamimura T, Iwasaki H, Ogawa R, Akashi K, Miyamoto T. Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma. International Journal of Hematology. PMID 31981096 DOI: 10.1007/s12185-020-02833-w  0.44
2019 Yoshida S, Ohno Y, Nagafuji K, Yoshimoto G, Sugio T, Kamimura T, Ohta T, Takase K, Henzan H, Muta T, Iwasaki H, Ogawa R, Eto T, Akashi K, Miyamoto T. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation. Annals of Hematology. PMID 31628517 DOI: 10.1007/s00277-019-03801-z  0.44
2019 Nagafuji K, Matsumura I, Shimose T, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Kadowaki N, Ishikawa J, Imamura Y, Yamazaki H, Akashi K, Kanakura Y. Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt). International Journal of Hematology. PMID 31538327 DOI: 10.1007/s12185-019-02736-5  0.44
2019 Kodama T, Kochi Y, Nakai W, Mizuno H, Baba T, Habu K, Sawada N, Tsunoda H, Shima T, Miyawaki K, Kikushige Y, Mori Y, Miyamoto T, Maeda T, Akashi K. Anti-GPRC5D/CD3 bispecific T cell-redirecting antibody for the treatment of multiple myeloma. Molecular Cancer Therapeutics. PMID 31270154 DOI: 10.1158/1535-7163.MCT-18-1216  0.44
2019 Nagafuji K, Miyamoto T, Eto T, Ogawa R, Okumura H, Takase K, Kawano N, Miyazaki Y, Fujisaki T, Wake A, Ohno Y, Kurokawa T, Kamimura T, Takamatsu Y, Yokota S, et al. Prospective evaluation of Minimal Residual Disease (MRD) monitoring to Predict Prognosis of Adult Patients with Ph-negative ALL. European Journal of Haematology. PMID 31132205 DOI: 10.1111/ejh.13268  0.44
2019 Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, Akashi K, Masuda S. Impact of , and Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences. 20. PMID 31096684 DOI: 10.3390/ijms20102413  0.44
2019 Aoki T, Kamimura T, Yoshida S, Mori Y, Kadowaki M, Kohno K, Ishihara D, Urata S, Sugio T, Kamezaki K, Kato K, Ito Y, Eto T, Akashi K, Miyamoto T. Safety and seropositivity after live attenuated vaccine in adult patients receiving hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30959161 DOI: 10.1016/j.bbmt.2019.04.006  0.44
2019 Sunami K, Matsumoto M, Fuchida SI, Omoto E, Takamatsu H, Adachi Y, Choi I, Fujishima N, Kiguchi T, Miyamoto T, Maeda A, Suzumiya J, Yamamura R, Nagafuji K, Nakazato T, et al. Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12). International Journal of Clinical Oncology. PMID 30937622 DOI: 10.1007/s10147-019-01436-8  0.44
2019 Minami M, Matsushima T, Mori Y, Ishihara D, Jinnnouchi F, Takenaka K, Henzan T, Yoshimoto G, Numata A, Kato K, Maeda T, Miyamoto T, Akashi K. Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody. Bone Marrow Transplantation. PMID 30804490 DOI: 10.1038/s41409-019-0486-4  0.44
2019 Ayano M, Tsukamoto H, Mitoma H, Kimoto Y, Akahoshi M, Arinobu Y, Miyamoto T, Horiuchi T, Niiro H, Nagafuji K, Harada M, Akashi K. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Arthritis Research & Therapy. 21: 30. PMID 30670057 DOI: 10.1186/s13075-019-1823-0  0.44
2018 Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M, et al. Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma. International Journal of Hematology. PMID 30406327 DOI: 10.1007/s12185-018-2557-5  0.44
2018 Uchida M, Nakamura T, Shima T, Yoshimoto G, Kato K, Hosohata K, Miyamoto T, Akashi K. Comparative Quantification of Chemotherapy-Induced Nausea and Emesis between the Common Terminology Criteria for Adverse Events and the Multinational Association of Supportive Care in Cancer Antiemesis Tool. Biological & Pharmaceutical Bulletin. 41: 1667-1671. PMID 30381666 DOI: 10.1248/bpb.b18-00336  0.44
2018 Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M, et al. A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma. International Journal of Hematology. PMID 30284685 DOI: 10.1007/s12185-018-2543-y  0.44
2018 Yamasaki S, Yoshimoto G, Kohno K, Henzan H, Aoki T, Tanimoto K, Sugio Y, Muta T, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Miyamoto T, Akashi K, et al. Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation. International Journal of Hematology. PMID 30251131 DOI: 10.1007/s12185-018-2538-8  0.44
2018 Sugio T, Miyawaki K, Kato K, Sasaki K, Yamada K, Iqbal J, Miyamoto T, Ohshima K, Maeda T, Miyoshi H, Akashi K. Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS. Blood Advances. 2: 2242-2252. PMID 30194138 DOI: 10.1182/bloodadvances.2018018754  0.44
2018 Sugita J, Kagaya Y, Miyamoto T, Shibasaki Y, Nagafuji K, Ota S, Furukawa T, Nara M, Akashi K, Taniguchi S, Harada M, Matsuo K, Teshima T. Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide. Bone Marrow Transplantation. PMID 30087460 DOI: 10.1038/s41409-018-0279-1  0.44
2018 Yoshimoto G, Mori Y, Kato K, Shima T, Miyawaki K, Kikushige Y, Kamezaki K, Numata A, Maeda T, Takenaka K, Iwasaki H, Teshima T, Akashi K, Miyamoto T. Human Herpes Virus-6-associated Encephalitis/Myelitis mimicking Calcineurin inhibitor induced pain syndrome in allogeneic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30026111 DOI: 10.1016/j.bbmt.2018.07.017  0.44
2018 Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, ... ... Miyamoto T, et al. Gastrointestinal graft-versus-host disease is a risk factor for post-engraftment blood stream infection in allogeneic hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29909153 DOI: 10.1016/j.bbmt.2018.06.002  0.44
2018 Mori Y, Yoshimoto G, Yuda JI, Hayashi M, Odawara J, Kuriyama T, Sugio T, Miyawaki K, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K. Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation. Leukemia & Lymphoma. 1-3. PMID 29741437 DOI: 10.1080/10428194.2018.1466295  0.44
2018 Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y. Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial). International Journal of Hematology. PMID 29362980 DOI: 10.1007/s12185-018-2401-y  0.44
2018 Uchida M, Nakamura T, Hata K, Watanabe H, Mori Y, Kato K, Kamezaki K, Takenaka K, Shiratsuchi M, Hosohata K, Miyamoto T, Akashi K. Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting. Journal of Pharmaceutical Health Care and Sciences. 4: 1. PMID 29345696 DOI: 10.1186/s40780-017-0097-4  0.44
2017 Miyamoto T, Nagafuji K, Fujisaki T, Uchida N, Matsue K, Henzan H, Ogawa R, Takase K, Aoki T, Hidaka M, Teshima T, Taniguchi S, Akashi K, Harada M. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission. International Journal of Hematology. PMID 29243031 DOI: 10.1007/s12185-017-2389-8  0.44
2017 Sasaki K, Mori Y, Yoshimoto G, Sakoda T, Kato K, Inadomi K, Kamezaki K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K. Successful treatment of Ph ALL with hematopoietic stem cell transplantation from the same HLA-haploidentical related donor of previous liver transplantation. Leukemia & Lymphoma. 1-3. PMID 29164981 DOI: 10.1080/10428194.2017.1403021  0.44
2017 Miyake N, Chong Y, Nishida R, Takenaka K, Kato K, Miyamoto T, Aono A, Takaki A, Mitarai S, Shimoda S, Shimono N, Akashi K. Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 28988958 DOI: 10.1016/j.jiac.2017.08.011  0.44
2017 Kikushige Y, Miyamoto T, Akashi K. Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 58: 1838-1843. PMID 28978822 DOI: 10.11406/rinketsu.58.1838  0.44
2017 Uchida M, Mori Y, Nakamura T, Kato K, Kamezaki K, Takenaka K, Shiratsuchi M, Kadoyama K, Miyamoto T, Akashi K. Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP. Biological & Pharmaceutical Bulletin. 40: 1499-1505. PMID 28867732 DOI: 10.1248/bpb.b17-00318  0.44
2017 Sakoda T, Kanamitsu Y, Mori Y, Sasaki K, Yonemitsu E, Nagae K, Yoshimoto G, Kamezaki K, Kato K, Takenaka K, Miyamoto T, Furue M, Iwasaki H, Akashi K. Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation. Internal Medicine (Tokyo, Japan). 56: 2481-2485. PMID 28824063 DOI: 10.2169/internalmedicine.8491-16  0.44
2017 Yuda J, Miyamoto T, Odawara J, Ohkawa Y, Semba Y, Hayashi M, Miyamura K, Tanimoto M, Yamamoto K, Taniwaki M, Akashi K. Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response. Cancer Science. PMID 28801986 DOI: 10.1111/cas.13353  0.44
2017 Minami M, Arita T, Iwasaki H, Muta T, Aoki T, Aoki K, Yamasaki S, Matsushima T, Kato K, Takenaka K, Tanimoto K, Kamimura T, Ogawa R, Akashi K, Miyamoto T. Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib. British Journal of Haematology. PMID 28340283 DOI: 10.1111/bjh.14608  0.44
2017 Miyawaki K, Iwasaki H, Jiromaru T, Kusumoto H, Yurino A, Sugio T, Uehara Y, Odawara J, Daitoku S, Kunisaki Y, Mori Y, Arinobu Y, Tsuzuki H, Kikushige Y, Iino T, ... ... Miyamoto T, et al. Identification of unipotent megakaryocyte progenitors in human hematopoiesis. Blood. PMID 28336526 DOI: 10.1182/blood-2016-09-741611  0.44
2016 Shimoji S, Hashimoto D, Tsujigiwa H, Miyawaki K, Kato K, Takahashi S, Ogasawara R, Jiromaru T, Iwasaki H, Miyamoto T, Akashi K, Teshima T. Graft-versus-host disease targets ovary and causes female infertility in mice. Blood. PMID 27903524 DOI: 10.1182/blood-2016-07-728337  0.44
2016 Tochigi T, Aoki T, Kikushige Y, Kamimura T, Ito Y, Shima T, Yamauchi T, Mori Y, Yoshimoto G, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Akashi K, Miyamoto T. Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs. International Journal of Hematology. PMID 27873175 DOI: 10.1007/s12185-016-2148-2  0.44
2016 Suetsugu K, Ikesue H, Miyamoto T, Shiratsuchi M, Yamamoto-Taguchi N, Tsuchiya Y, Matsukawa K, Uchida M, Watanabe H, Akashi K, Masuda S. Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. PMID 27822915 DOI: 10.1007/s12185-016-2135-7  0.44
2016 Miyamoto T, Takashima S, Kato K, Takase K, Yoshimoto G, Yoshida S, Henzan H, Osaki K, Kamimura T, Iwasaki H, Eto T, Teshima T, Nagafuji K, Akashi K. Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation. International Journal of Hematology. PMID 27686673 DOI: 10.1007/s12185-016-2093-0  0.44
2016 Yurino A, Takenaka K, Yamauchi T, Nunomura T, Uehara Y, Jinnouchi F, Miyawaki K, Kikushige Y, Kato K, Miyamoto T, Iwasaki H, Kunisaki Y, Akashi K. Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations. Stem Cell Reports. PMID 27499200 DOI: 10.1016/j.stemcr.2016.07.002  0.44
2016 Shima T, Kamezaki K, Higashioka K, Takashima S, Yoshimoto G, Kato K, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K. Ascites Retention during Mogamulizumab Treatment in a Patient with Adult T-cell Leukemia/lymphoma. Internal Medicine (Tokyo, Japan). 55: 1793-6. PMID 27374686 DOI: 10.2169/internalmedicine.55.5987  0.44
2016 Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, ... ... Miyamoto T, et al. Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27220263 DOI: 10.1016/j.bbmt.2016.05.017  0.44
2016 Daitoku S, Takenaka K, Yamauchi T, Yurino A, Jinnouchi F, Nunomura T, Eto T, Kamimura T, Higuchi M, Harada N, Saito N, Miyamoto T, Iwasaki H, Akashi K. Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis. Experimental Hematology. 44: 817-825.e3. PMID 27185380 DOI: 10.1016/j.exphem.2016.05.001  0.44
2016 Kuriyama T, Kato K, Sakamoto K, Hayashi M, Takashima S, Mori Y, Takenaka K, Iwasaki H, Teshima T, Harada N, Nagafuji K, Miyamoto T, Akashi K. Cord Blood Transplantation Following Reduced-intensity Conditioning for Adult-onset Inherited Hemophagocytic Lymphohistiocytosis. Internal Medicine (Tokyo, Japan). 55: 667-71. PMID 26984088 DOI: 10.2169/internalmedicine.55.5241  0.44
2016 Kitanaka A, Takenaka K, Shide K, Miyamoto T, Kondo T, Ozawa K, Kurokawa M, Akashi K, Shimoda K. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients. International Journal of Hematology. 103: 423-8. PMID 26791378 DOI: 10.1007/s12185-016-1940-3  0.44
2015 Takashima S, Miyamoto T, Kamimura T, Yoshimoto G, Yoshida S, Henzan H, Takase K, Kato K, Ito Y, Ohno Y, Nagafuji K, Eto T, Teshima T, Akashi K. Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. International Journal of Hematology. PMID 26475283 DOI: 10.1007/s12185-015-1883-0  0.44
2015 Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi S, Niiro H, Yurino A, Miyawaki K, Takenaka K, Iwasaki H, Akashi K. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression. Cell Stem Cell. 17: 341-52. PMID 26279267 DOI: 10.1016/j.stem.2015.07.011  0.44
2015 Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, Teshima T. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1646-52. PMID 26093044 DOI: 10.1016/j.bbmt.2015.06.008  0.44
2015 Minami M, Shima T, Kato K, Yamamoto H, Tsuchihashi K, Oku S, Shimokawa T, Tochigi T, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Oda Y, Miyamoto T, Akashi K. Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy. International Journal of Hematology. PMID 25753226 DOI: 10.1007/s12185-015-1778-0  0.44
2015 Uryu H, Hashimoto D, Kato K, Hayase E, Matsuoka S, Ogasawara R, Takahashi S, Maeda Y, Iwasaki H, Miyamoto T, Saijo S, Iwakura Y, Hill GR, Akashi K, Teshima T. α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice. Blood. 125: 3014-23. PMID 25740827 DOI: 10.1182/blood-2014-12-615781  0.44
2015 Yamasaki S, Yoshimoto G, Ogawa R, Aoki K, Higuchi M, Harada N, Arima F, Kondo S, Matubara F, Takahashi T, Uike N, Miyamoto T, Okamura S, Akashi K. Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics. Annals of Hematology. 94: 1159-65. PMID 25704584 DOI: 10.1007/s00277-015-2338-7  0.44
2015 Miyawaki K, Arinobu Y, Iwasaki H, Kohno K, Tsuzuki H, Iino T, Shima T, Kikushige Y, Takenaka K, Miyamoto T, Akashi K. CD41 marks the initial myelo-erythroid lineage specification in adult mouse hematopoiesis: redefinition of murine common myeloid progenitor. Stem Cells (Dayton, Ohio). 33: 976-87. PMID 25446279 DOI: 10.1002/stem.1906  0.44
2015 Ito Y, Miyamoto T, Kamimura T, Aoki K, Henzan H, Aoki T, Shiratsuchi M, Kato K, Nagafuji K, Ogawa R, Eto T, Iwasaki H, Akashi K. Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation. Clinical Lymphoma, Myeloma & Leukemia. 15: e47-54. PMID 25445469 DOI: 10.1016/j.clml.2014.09.006  0.44
2014 Shima T, Miyamoto T, Kikushige Y, Yuda J, Tochigi T, Yoshimoto G, Kato K, Takenaka K, Iwasaki H, Mizuno S, Goto N, Akashi K. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell. Experimental Hematology. 42: 955-65.e1-5. PMID 25101977 DOI: 10.1016/j.exphem.2014.07.267  0.44
2014 Kamimura T, Miyamoto T, Yokota N, Aoki T, Ito Y, Akashi K. Peripheral neuropathy exacerbated by lenalidomide in a patient with multiple myeloma. Internal Medicine (Tokyo, Japan). 53: 1651-3. PMID 25088880 DOI: DN/JST.JSTAGE/internalmedicine/53.1354  0.44
2014 Takashima S, Eto T, Shiratsuchi M, Hidaka M, Mori Y, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, et al. The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) group. Internal Medicine (Tokyo, Japan). 53: 1315-20. PMID 24930650 DOI: DN/JST.JSTAGE/internalmedicine/53.1858  0.44
2014 Takashima S, Miyamoto T, Kadowaki M, Ito Y, Aoki T, Takase K, Shima T, Yoshimoto G, Kato K, Muta T, Shiratsuchi M, Takenaka K, Iwasaki H, Teshima T, Kamimura T, et al. Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients. International Journal of Hematology. 100: 159-64. PMID 24928523 DOI: 10.1007/s12185-014-1611-1  0.44
2014 Ikesue H, Tsuji T, Hata K, Watanabe H, Mishima K, Uchida M, Egashira N, Miyamoto T, Baba E, Akashi K, Takayama K, Nakanishi Y, Tokunaga E, Okamoto T, Maehara Y, et al. Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer. The Annals of Pharmacotherapy. 48: 1159-1165. PMID 24928100 DOI: 10.1177/1060028014539919  0.44
2014 Yuda J, Kato K, Kikushige Y, Ohkusu K, Kiyosuke M, Sakamoto K, Oku S, Miyake N, Kadowaki M, Iino T, Tanimoto K, Takenaka K, Iwasaki H, Miyamoto T, Shimono N, et al. Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia. Internal Medicine (Tokyo, Japan). 53: 1087-91. PMID 24827491 DOI: DN/JST.JSTAGE/internalmedicine/53.1366  0.44
2014 Chong Y, Shimoda S, Yakushiji H, Ito Y, Aoki T, Miyamoto T, Kamimura T, Shimono N, Akashi K. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis. Plos One. 9: e85210. PMID 24465506 DOI: 10.1371/journal.pone.0085210  0.44
2014 Iwamoto C, Takenaka K, Urata S, Yamauchi T, Shima T, Kuriyama T, Daitoku S, Saito Y, Miyamoto T, Iwasaki H, Kitabayashi I, Itoh K, Kishimoto J, Kohda D, Matozaki T, et al. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment. Experimental Hematology. 42: 163-171.e1. PMID 24269920 DOI: 10.1016/j.exphem.2013.11.005  0.44
2013 Kamimura T, Miyamoto T, Yokota N, Aoki T, Ito Y, Akashi K. High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib. International Journal of Hematology. 98: 694-701. PMID 24249047 DOI: 10.1007/s12185-013-1469-7  0.44
2013 Yamasaki S, Muta T, Higo T, Kusumoto H, Zaitsu E, Miyamoto T, Oda Y, Akashi K. Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis. Hematology Reports. 5: e12. PMID 24179667 DOI: 10.4081/hr.2013.e12  0.44
2013 Ito Y, Miyamoto T, Kamimura T, Takase K, Henzan H, Sugio Y, Kato K, Ohno Y, Eto T, Teshima T, Akashi K. Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group. International Journal of Hematology. 98: 463-71. PMID 24043582 DOI: 10.1007/s12185-013-1430-9  0.44
2013 Nakaike T, Kato K, Oku S, Hayashi M, Kikushige Y, Kuroiwa M, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Ohshima K, Akashi K. Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides. International Journal of Hematology. 98: 491-5. PMID 23943312 DOI: 10.1007/s12185-013-1410-0  0.44
2013 Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T. Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1525-9. PMID 23927965 DOI: 10.1016/j.bbmt.2013.07.027  0.44
2013 Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Takamatsu Y, Teshima T, Akashi K. Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma. International Journal of Hematology. 98: 337-45. PMID 23877150 DOI: 10.1007/s12185-013-1402-0  0.44
2013 Eto T, Takase K, Miyamoto T, Ohno Y, Kamimura T, Nagafuji K, Takamatsu Y, Teshima T, Gondo H, Taniguchi S, Akashi K, Harada M. Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission. International Journal of Hematology. 98: 186-96. PMID 23754766 DOI: 10.1007/s12185-013-1378-9  0.44
2003 Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proceedings of the National Academy of Sciences of the United States of America. 100: 10002-7. PMID 12890867 DOI: 10.1073/pnas.1633833100  0.64
2003 Terskikh AV, Miyamoto T, Chang C, Diatchenko L, Weissman IL. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood. 102: 94-101. PMID 12623852 DOI: 10.1182/blood-2002-08-2509  0.64
2003 Nakorn TN, Miyamoto T, Weissman IL. Characterization of mouse clonogenic megakaryocyte progenitors. Proceedings of the National Academy of Sciences of the United States of America. 100: 205-10. PMID 12490656 DOI: 10.1073/pnas.262655099  0.64
2002 Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic common myeloid progenitors. Proceedings of the National Academy of Sciences of the United States of America. 99: 11872-7. PMID 12193648 DOI: 10.1073/pnas.172384399  0.64
2002 Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL, Akashi K. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Developmental Cell. 3: 137-47. PMID 12110174  0.64
Show low-probability matches.